Dr. Omid Yazdanpanah completed his Doctor of Medicine (MD) degree at Kerman University of Medical Sciences in Iran before pursuing a residency in internal medicine at Wayne State University in Detroit, Michigan (July 2019-June 2022). He is a board-certified Internal Medicine physician. In July 2022, he joined the University of California Irvine to begin his Hematology and Oncology Fellowship. Currently, he holds the position of Hematology and Oncology Fellow at the Division of Hematology and Oncology, Department of Medicine, University of California Irvine Medical Center in Orange, CA, USA. Dr.Yazdanpanah's research interests lie in medical oncology, particularly focusing on genitourinary oncology including prostate, bladder, kidney, and testicular cancer. He has authored numerous peer-reviewed publications in this field. He is also an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Association of Cancer Research (AACR) and has presented his studies in several national and international cancer conferences.
Dr. Omid Yazdanpanah completed his Doctor of Medicine (MD) degree at Kerman University of Medical Sciences in Iran before pursuing a residency in internal medicine at Wayne State University in Detroit, Michigan (July 2019-June 2022). He is a board-certified Internal Medicine physician. In July 2022, he joined the University of California Irvine to begin his Hematology and Oncology Fellowship. Currently, he holds the position of Hematology and Oncology Fellow at the Division of Hematology and Oncology, Department of Medicine, University of California Irvine Medical Center in Orange, CA, USA. Dr.Yazdanpanah's research interests lie in medical oncology, particularly focusing on genitourinary oncology including prostate, bladder, kidney, and testicular cancer. He has authored numerous peer-reviewed publications in this field. He is also an active member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and American Association of Cancer Research (AACR) and has presented his studies in several national and international cancer conferences.